Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hironori Yoshiyama

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Cancers|June 10, 2023
How Should We Deal with Neoplastic Disease and Serious Infections Caused by Epstein-Barr Virus?Hironori Yoshiyama, Asuka Nanbo, Tomoharu Yasuda
Journal of Virology|September 15, 2005
Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cellsAsuka Nanbo, Hironori Yoshiyama, Kenzo Takada
Frontiers in Microbiology|June 6, 2018
The Role of Transforming Growth Factor β in Cell-to-Cell Contact-Mediated Epstein-Barr Virus TransmissionAsuka Nanbo, Makoto Ohashi, Hironori Yoshiyama, et al.
Journal of Virology|July 19, 2013
Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cellsAsuka Nanbo, Eri Kawanishi, Ryuji Yoshida, et al.
American Journal of Cancer Research|September 8, 2012
Regulation of cancer stem cell activities by tumor-associated macrophagesMasahisa Jinushi, Muhammad Baghdadi, Shigeki Chiba, et al.
The Journal of General Virology|September 23, 2016
Epstein-Barr virus exploits host endocytic machinery for cell-to-cell viral transmission rather than a virological synapseAsuka Nanbo, Kunihiro Kachi, Hironori Yoshiyama, et al.
Trends in Molecular Medicine|July 2, 2013
Putting the brakes on anticancer therapies: suppression of innate immune pathways by tumor-associated myeloid cellsMasahisa Jinushi, Hideo Yagita, Hironori Yoshiyama, et al.
Cancer Science|March 12, 2011
Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphomaKosuke Miyauchi, Emiko Urano, Hironori Yoshiyama, et al.
Plos One|July 5, 2012
MFG-E8 regulates the immunogenic potential of dendritic cells primed with necrotic cell-mediated inflammatory signalsMuhammad Baghdadi, Shigeki Chiba, Tsunaki Yamashina, et al.
Cancer Science|November 19, 2013
Enhanced susceptibility of B lymphoma cells to measles virus by Epstein-Barr virus type III latency that upregulates CD150/signaling lymphocytic activation moleculeSatoshi Takeda, Daiki Kanbayashi, Takako Kurata, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Cancers|June 10, 2023
How Should We Deal with Neoplastic Disease and Serious Infections Caused by Epstein-Barr Virus?Hironori Yoshiyama, Asuka Nanbo, Tomoharu Yasuda
Journal of Virology|September 15, 2005
Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cellsAsuka Nanbo, Hironori Yoshiyama, Kenzo Takada
Frontiers in Microbiology|June 6, 2018
The Role of Transforming Growth Factor β in Cell-to-Cell Contact-Mediated Epstein-Barr Virus TransmissionAsuka Nanbo, Makoto Ohashi, Hironori Yoshiyama, et al.
Journal of Virology|July 19, 2013
Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cellsAsuka Nanbo, Eri Kawanishi, Ryuji Yoshida, et al.
American Journal of Cancer Research|September 8, 2012
Regulation of cancer stem cell activities by tumor-associated macrophagesMasahisa Jinushi, Muhammad Baghdadi, Shigeki Chiba, et al.
The Journal of General Virology|September 23, 2016
Epstein-Barr virus exploits host endocytic machinery for cell-to-cell viral transmission rather than a virological synapseAsuka Nanbo, Kunihiro Kachi, Hironori Yoshiyama, et al.
Trends in Molecular Medicine|July 2, 2013
Putting the brakes on anticancer therapies: suppression of innate immune pathways by tumor-associated myeloid cellsMasahisa Jinushi, Hideo Yagita, Hironori Yoshiyama, et al.
Cancer Science|March 12, 2011
Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphomaKosuke Miyauchi, Emiko Urano, Hironori Yoshiyama, et al.
Plos One|July 5, 2012
MFG-E8 regulates the immunogenic potential of dendritic cells primed with necrotic cell-mediated inflammatory signalsMuhammad Baghdadi, Shigeki Chiba, Tsunaki Yamashina, et al.
Cancer Science|November 19, 2013
Enhanced susceptibility of B lymphoma cells to measles virus by Epstein-Barr virus type III latency that upregulates CD150/signaling lymphocytic activation moleculeSatoshi Takeda, Daiki Kanbayashi, Takako Kurata, et al.
Pageof 6